Transforming the online learning space through advanced development retreats

Learning technologies have the potential to transform Higher Education, although multifaceted demands on staff time, confidence and training in using new technologies, and a lack of support can make this transformation difficult. The University of Huddersfield recently transitioned to a new virtual learning environment (VLE), which provided the opportunity to change the way staff view and use the new VLE for teaching and learning. As part of this project, three off-site retreats were run to help staff to reflect on and develop their teaching practice to better support student learning in the digital space and develop advanced online resources that support the democratisation of learning, close differential attainment gaps and give every student the best chance of success. Although much is written about different models of practice, there is a lack of theory and conceptualisation around changing practice. Examining the motivations and experiences of staff who participated provides insight into the challenges of implementing change on an institutional level, whilst examining their setup and design highlights ways to support staff during this process. Using participant feedback and experiences to underpin this research, we explore the immediate and ongoing outcomes of these off-site retreats to help transform the University’s approach to technology-enhanced learning.

Futures Thinking, Foresight Practice, and Macro Social Work

Macro social work has a long tradition of emphasizing planning. This array of practices typically looks at important intersections of community needs, resources, policies, and well-being—all of which combine to reflect, guide, and support the aspirations of groups, organizations, and communities. Futures thinking and foresight practice are an important emerging, but underutilized, set of ideas and tools available to macro-level social work practitioners and scholars to better navigate rapidly changing practice ecosystems. They have the ability to update and multiply traditional planning approaches. Futures thinking and foresight practice can have applications in numerous areas of practice, including (a) equity practice, (b) community practice, (c) organizational practice, and (d) government/policy practice. Social work ethics is likely to continue adapting to the changing world.

Conventional Synthetic Dmards in Psoriatic Arthritis: Changing Practice in Biologic Era; Real-Life Results from HURBIO-PsA Registry

Objectives: Psoriatic arthritis is a chronic musculoskeletal disorder which may affect skin, joints, bone and enthesis. Conventional synthetic disease modifying anti-rheumatic drugs are first-line treatment options and biologic disease modifying anti-rheumatic drugs are recommended in psoriatic arthritis patients who are intolerant/not controlled well with conventional synthetic disease modifying anti-rheumatic drugs. Although survival data of the conventional synthetic disease modifying anti-rheumatic drugs without concomitant biologic disease modifying anti-rheumatic drugs are available, the effect of biologic disease modifying anti-rheumatic drugs on the retention of conventional synthetic disease modifying anti-rheumatic drugs is still a question of interest. Materials and Methods: Psoriatic arthritis patients who received at least 1 dose of biologic disease modifying anti-rheumatic drugs, using at least 1 conventional synthetic disease modifying anti-rheumatic drugs (methotrexate, leflunomide, hydroxychloroquine and sulfasalazine) at the time of biologic disease modifying anti-rheumatic drugs starting visit and registered in the Hacettepe University BIOlogical Database-Psoriatic Arthritis were included in this retrospective longitudinal analysis. Demographic and disease-specific data at first and last follow-up visit were collected. Unadjusted retention rate of each conventional synthetic disease modifying anti-rheumatic drugs was assessed. Overall prescription of conventional synthetic disease modifying anti-rheumatic drugs at first and last follow-up visit were compared. Results: A total of 266 (191(71.8%) female) patients was included. Median follow-up duration under biologic treatment was 43.4 (19.4-80.1) months. Median retention duration of each conventional synthetic disease modifying anti-rheumatic drugs were similar. Between the first and last visit; there was a 29.3% decrease in methotrexate use (61.7% vs. 43.6%; p<0.001), 8.4% decrease in leflunomide use (31.2% vs. 28.6%; p=0.30), 30.0% decrease in sulfasalazine use (11.3% vs. 7.9%; p=0.05), 31.1% decrease in hydroxychloroquine use (16.9% vs. 11.7%; p=0.001), 12.5 % decrease in glucocorticoids use (51.1% vs. 44.7%; p=0.015). At last visit, 59 (22.2%) patients were conventional synthetic disease modifying anti-rheumatic drugs -free: 20 (7.5%) patients were using only glucocorticoids, 39 (14.7%) patients were conventional synthetic disease modifying anti-rheumatic drugs + glucocorticoid-free. Conclusion: Although conventional synthetic disease modifying anti-rheumatic drugs were significantly discontinued in an important percent of patients after the initiation of biologic disease modifying anti-rheumatic drugs, percentage of patients using glucocorticoids at last visit was still high. Studies aiming to demonstrate when, in whom and how to discontinue conventional synthetic disease modifying anti-rheumatic drugs are needed.

Nursing Care of the Chronically Critically ill: An Exploratory Descriptive Study

<p>Background:There is an emerging group of intensive care unit (ICU) patients known as the chronically critically ill (CCI). This patient group is steadily increasing worldwide (Nelson et al., 2004).No published literature was located that focused on the nursing experience of caring for CCI patients, however studies alluded to CCI patients as frustrating to look after.This is pertinent because these patients are costly to care for and considered burdensome to nurses and physicians. (Daly, Rudy, Thompson & Happ, 1991). In a working environment where turnover and shortage of nursing staff is evident and predicted to worsen, this is cause for real concern about future resourcing for this patient group (Carasa & Nespoli, 2002). Research Aims: The aim of this study was to explore and describe nurses' experiences of caring for CCI patients. ICU nurses are the key providers of bedside care to all ICU patients. They have valuable contributions concerning the planning and implementation of patient-focused care, including that of long-stay and CCI patients. Method: A qualitative approach was used with an exploratory descriptive design. Semistructured interviews were conducted which generated in-depth description of participant experiences. Findings: Six key themes are identified: 1. Nursing autonomy and control 2. Work-related stress, compassion fatigue and staff allocation 3. The CCI patient in the ICU environment 4. Teamwork, nursing practice and continuity of care 5. The culture of ICU 6. Withdrawal of care and palliation. Summary: Six nurses from two tertiary level ICUs within New Zealand were interviewed using a semi-structured approach. Participants were encouraged to comment on several issues including access to training and resources, cultural issues within ICU and any suggestions for how CCI patient care might be improved.The interviews were transcribed to allow a thorough content analysis. These topics were explored and generated recommendations for changing practice.</p>

Nursing Care of the Chronically Critically ill: An Exploratory Descriptive Study

<p>Background:There is an emerging group of intensive care unit (ICU) patients known as the chronically critically ill (CCI). This patient group is steadily increasing worldwide (Nelson et al., 2004).No published literature was located that focused on the nursing experience of caring for CCI patients, however studies alluded to CCI patients as frustrating to look after.This is pertinent because these patients are costly to care for and considered burdensome to nurses and physicians. (Daly, Rudy, Thompson & Happ, 1991). In a working environment where turnover and shortage of nursing staff is evident and predicted to worsen, this is cause for real concern about future resourcing for this patient group (Carasa & Nespoli, 2002). Research Aims: The aim of this study was to explore and describe nurses' experiences of caring for CCI patients. ICU nurses are the key providers of bedside care to all ICU patients. They have valuable contributions concerning the planning and implementation of patient-focused care, including that of long-stay and CCI patients. Method: A qualitative approach was used with an exploratory descriptive design. Semistructured interviews were conducted which generated in-depth description of participant experiences. Findings: Six key themes are identified: 1. Nursing autonomy and control 2. Work-related stress, compassion fatigue and staff allocation 3. The CCI patient in the ICU environment 4. Teamwork, nursing practice and continuity of care 5. The culture of ICU 6. Withdrawal of care and palliation. Summary: Six nurses from two tertiary level ICUs within New Zealand were interviewed using a semi-structured approach. Participants were encouraged to comment on several issues including access to training and resources, cultural issues within ICU and any suggestions for how CCI patient care might be improved.The interviews were transcribed to allow a thorough content analysis. These topics were explored and generated recommendations for changing practice.</p>

Practice-enhancing publications about the medication-use process in 2020

Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose This article identifies, prioritizes, and summarizes published literature on the medication-use process (MUP) from calendar year 2020 that can impact health-system pharmacy daily practice. Summary The MUP is the foundational system that provides the framework for safe medication utilization within the healthcare environment. The MUP is defined in this article as having the following components: prescribing/transcribing, dispensing, administration, and monitoring. Articles evaluating at least one step of the MUP were assessed for their usefulness in practice improvement. A PubMed search for articles published in calendar year 2020 was conducted in January 2021 using targeted Medical Subject Headings (MeSH) keywords, and the table of contents of selected pharmacy journals was searched, providing a total of 9,433 articles. A thorough review identified 49 potentially practice-enhancing articles: 15 for prescribing/transcribing, 10 for dispensing, 6 for administration, and 18 for monitoring. Ranking of the articles for importance by peers led to the selection of key articles from each category. The highest-ranked articles are briefly summarized, with a mention of why they are important within health-system pharmacy. The other articles are listed for further review and evaluation. Conclusion It is important to routinely review the published literature and to incorporate significant findings into daily practice. This article assists in identifying and summarizing the most impactful recently published literature. Health-system pharmacists have an active role in improving the MUP in their institution, and awareness of the moist significant published studies can assist in changing practice at the institutional level.

Pancreaticobiliary endoscopic ultrasound in England 2007 to 2016: Changing practice and outcomes

Background and study aims Population-level data on the outcomes of pancreaticobiliary endoscopic ultrasound (PB-EUS) are limited. We examined national PB-EUS and fine-needle aspiration (FNA) activity, its relation to pancreatic cancer therapy, associated mortality and adverse events. Patients and methods Adults undergoing PB-EUS in England from 2007–2016 were identified in Hospital Episode Statistics. A pancreatic cancer cohort diagnosed within 6 months of PB-EUS were studied separately. Multivariable logistic regression models examined associations with 30-day mortality and therapies for pancreatic cancer. Results 79,269 PB-EUS in 68,908 subjects were identified. Annual numbers increased from 2,874 (28 % FNA) to 12,752 (35 % FNA) from 2007 to 2016. 8,840 subjects (13 %) were diagnosed with pancreatic cancer. Sedation related adverse events were coded in 0.5 % and emergency admission with acute pancreatitis in 0.2 % within 48 hours of PB-EUS. 1.5 % of subjects died within 30 days of PB-EUS. Factors associated with 30-day mortality included increasing age (odds ratio 1.03 [95 % CI 1.03–1.04]); male sex (1.38 [1.24–1.56]); increasing comorbidity (1.49 [1.27–1.74]); EUS-FNA (2.26 [1.98–2.57]); pancreatic cancer (1.39 [1.19–1.62]); increasing deprivation (least deprived quintile 0.76 [0.62–0.93]) and lower provider PB-EUS volume (2.83 [2.15–3.73]). Factors associated with surgical resection in the pancreatic cancer cohort included lower provider PB-EUS volume (0.44 [0.26–0.74]) and the least deprived subjects (1.33 [1.12–1.57]). 33 % of pancreatic cancer subjects who underwent EUS, did not subsequently receive active cancer treatment. Conclusions Lower provider PB-EUS volume was associated with higher 30-day mortality and reduced rates of both pancreatic cancer surgery and chemotherapy. These results suggest potential issues with case selection in lower-volume EUS providers.

1126. Short-Course Therapy and Transition to Enteral Antibiotics for Uncomplicated Bacteremia Due to Enterobacterales Species

Background Gram-negative bacteremia historically has been treated with 10-14 days of parenteral antibiotics. However, data supporting this practice are lacking, and recent evidence shows equivalent outcomes for short-course (SC) therapy (7 days) and early (by day 5) conversion to highly bioavailable enteral (PO) antibiotics for Enterobacterales bacteremia. Methods Under a QI framework, we used PDSA cycles to reduce treatment duration and increase use of PO levofloxacin or trimethoprim-sulfamethoxazole for uncomplicated Enterobacterales bacteremia among Infectious Diseases (ID) clinicians at a children’s hospital in Boston, MA. We conducted an education session on evidence to support these practices for ID faculty and fellows in October 2020. In December 2020, we implemented standardized recommendations for a 7-day duration and early PO transition for eligible patients (≥ 3-months-old, ≤ 2 days monomicrobial bacteremia, with source control and return to baseline clinical status) that could be inserted automatically into electronic consult notes. In February 2021, we reinforced this practice to ID providers. We collected data before and after these interventions on ID recommendations and on patients’ actual antibiotic management. Results From 11/01/20 to 05/31/21, mean recommended treatment decreased from 10.6 to 9.5 days; however, mean duration received was similar (11.2 vs 11.7 days) (Figure 1). The percentage of patients for whom ID recommended PO conversion and in whom transition to PO agents by day 5 occurred increased from 27% to 37.5%. Figure 1. Change in average duration of antibiotics recommended and received, in days Conclusion Education and creation of automated standardized recommendations led to decreased recommended treatment durations and increased PO conversions for Enterobacterales bacteremia, but only modestly. This quality improvement initiative demonstrates the potential benefits of education and electronic documentation tools to facilitate evidence-based practice changes, but also highlights the difficulty in changing practice even amongst ID clinicians. Further PDSA cycles will be targeted at increasing more consistent awareness among a large ID division in addition to other stakeholders. Disclosures Gabriella S. Lamb, MD, MPH, Nothing to disclose